June 2 (SeeNews) - Bulgarian drug maker Sopharma [BUL:SFA] said that its consolidated net profit rose to some 18.1 million levs ($9.2 million/11.3 million euro) in the first three months of 2021 from 10.8 million levs in the comparable period of 2020.